Showing 14 RESULTS FOR
Results from the DELIVER study with VYEPTI® (eptinezumab-jjmr) has been published in a top-ranking medical journal
The primary and key secondary results on VYEPTI® (eptinezumab-jjmr) from the DELIVER study in patients with migraine and prior preventive treatment failures are now published in the high-impact medical journal Lancet Neurology.
Dr. Roger Cady Recognized for Contribution to Migraine Medicine
Dr. Cady, a pioneer in migraine research, shares his hopes for the future of migraine care.
Spotlight on Migraine Podcast: The Evolution of Migraine Disease
Dr. Roger Cady on why some people transition from episodic migraine to chronic migraine.